MAIA Biotechnology MAIA
NYSE MAIA
$1.13 +0.01 (+1.33%)
As of: Oct 21, 2026 · 3:59 PM EDT

MAIA Biotechnology (MAIA) Change in Receivables (2022 - 2023)

Updated

MAIA Biotechnology (MAIA) posted Change in Receivables of $16,208 for Q4 2023, down 58.7% from $39,207 a year earlier.

Analysis

MAIA Biotechnology (MAIA) Change in Receivables (2022 - 2023) Analysis & Trends

For FY2023, MAIA Biotechnology's Change in Receivables came in at -$158,405.

  • In prior years, MAIA Biotechnology's Change in Receivables was $269,395 in FY2022.
  • Quarterly Change in Receivables has run from a low of -$265,622 in Q3 2023 to a high of $65,111 in Q3 2022 over five years.
  • According to Business Quant data, Change in Receivables for the three prior quarters was -$265,622 (Q3 2023), $39,766 (Q2 2023) and $51,243 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.35 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 1.37 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 333.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 MAIA Biotechnology 69.31 Mn -12.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 16,208.00
Sep 30, 2023 -265,622.00
Jun 30, 2023 39,766.00
Mar 31, 2023 51,243.00
Dec 31, 2022 39,207.00
Sep 30, 2022 65,111.00
API Access

MAIA Biotechnology Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=MAIA&period=max&api_key=YOUR_API_KEY